Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype

Scandinavian Journal of Immunology

Volumn 63, Issue 6, 2006, Pages 410-419

  Bandholtz, L ^a,b   Ekman, G Jacobsson ^a   Vilhelmsson, M ^a   Buentke, E ^a   Agerberth, B ^a   Scheynius, A ^a   Gudmundsson, G H ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD86 ANTIGEN; HLA DR ANTIGEN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CELL NUCLEUS; CELL TRANSPORT; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INTRACELLULAR FLUID; MOLECULAR SEQUENCE DATA; MONOCYTES;

EID: 33745596163     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.001752.x     Document Type: Article

References (54)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
2. Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-7.
3. Wilson CL, Ouellette AJ, Satchell DP et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-7.
4. Heilborn JD, Nilsson MF, Kratz G et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003;120:379-89.
5. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002;169:3883-91.
6. Lillard JW Jr, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci USA 1999;96:651-6.
7. Davidson DJ, Currie AJ, Reid GS et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 2004;172:1146-56.
8. Yang D, Chertov O, Oppenheim JJ. The role of mammalian anti-microbial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 2001;58:978-89.
9. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997;90:2796-803.
10. Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086-93.
11. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995;92:195-9.
12. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998;95:9541-6.
13. Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999;67:2561-6.
14. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001;117:91-7.
15. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
16. Agerberth B & Gudmundsson GH. Human cathelicidin antimicrobial peptide LL-37. In: Oppenheim JJ, Feldmann M, eds, Cytokine Reference. San Diego: Academic Press, 2003.
17. Yang D, Chen Q, Schmidt AP et al. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-74.
18. Tjabringa GS, Aarbiou J, Ninaber DK et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003;171:6690-6.
19. Bowdish DM, Davidson DJ, Speert DP, Hancock RE. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 2004;172:3758-65.
20. Niyonsaba F, Iwabuchi K, Someya A et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002;106:20-6.
21. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004;172:4987-94.
22. Braff MH, Hawkins MA, Di Nardo A et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 2005;174:4271-8.
23. Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock RE. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun 2005;73:583-91.
24. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996;238:325-32.
25. Buentke E, Heffler LC, Wallin RP, Lofman C, Ljunggren HG, Scheynius A. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy 2001;31:1583-93.
26. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
27. Buentke E, Heffler LC, Wilson JL et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin - Malassezia-influenced cell interaction. J Invest Dermatol 2002;119:850-7.
28. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-51.
29. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997;77:759-803.
30. Schmid SL, Carter LL. ATP is required for receptor-mediated endocytosis in intact cells. J Cell Biol 1990;111:2307-18.
31. Sai Y, Kajita M, Tamai I, Wakama J, Wakamiya T, Tsuji A. Adsorptive-mediated endocytosis of a basic peptide in enterocyte-like Caco-2 cells. Am J Physiol 1998;275:G514-20.
32. Palliser D, Guillen E, Ju M, Eisen HN. Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells. J Immunol 2005;174:1879-87.
33. Montiel M, Quesada J, Jimenez E. Activation of second messenger-dependent protein kinases induces muscarinic acetylcholine receptor desensitization in rat thyroid epithelial cells. Mol Cell Endocrinol 2004;223:35-41.
34. Foley KF, De Frutos S, Laskovski KE, Tegge W, Dostmann WR. Culture conditions influence uptake and intracellular localization of the membrane permeable cGMP-dependent protein kinase inhibitor DT-2. Front Biosci 2005;10:1302-12.
35. Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 2003;278:1310-5.
36. Koczulla R, von Degenfeld G, Kupatt C et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003;111:1665-72.
37. Yang D, Chen Q, Le Y, Wang JM, Oppenheim JJ. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J Immunol 2001;166:4092-8.
38. Coutinho-Silva R, Persechini PM, Bisaggio RD et al. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999;276:C1139-47.
39. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-78.
40. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004;76:514-9.
41. Sandgren S, Wittrup A, Cheng F et al. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 2004;279:17951-6.
42. Richard JP, Melikov K, Vives E et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003;278:585-90.
43. Penco S, Scarfi S, Giovine M et al. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 2001;34:151-9.
44. Son KN, Park J, Chung CK, Chung DKYuDY, Lee KK, Kim J. Human lactoferrin activates transcription of IL-1beta gene in mammalian cells. Biochem Biophys Res Commun 2002;290:236-41.
45. Masjedi K, Jakobson E, Boman HG, Karlberg AT, Scheynius A. The antimicrobial peptide LL-37 upregulates HLA-DR molecules on dendritic cells. 11th International Congress of Immunology. Scand J Immunol 2001;54 (Suppl. 1): 74.
46. Raymond CR, Wilkie BN. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Vet Immunol Immunopathol 2005;15:235-47.
47. Steinman RM. Some interfaces of dendritic cell biology. Apmis 2003;111:675-97.
48. West MA, Wallin RP, Matthews SP et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 2004;305:1153-7.
49. Silberberg I. Apposition of mononuclear cells to Langerhans cells in contact allergic reactions. An ultrastructural study. Acta Derm Venereol 1973;53:1-12.
50. Scheynius A, Klareskog L, Forsum U. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol 1982;49:325-30.
51. Huang FP, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000;191:435-44.
52. Kobayashi H, Miura S, Nagata H et al. In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J Leukoc Biol 2004;75:434-42.
53. Geissmann F, Dieu-Nosjean MC, Dezutter C et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002;196:417-30.
54. Stoitzner P, Holzmann S, McLellan AD et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 2003;120:266-74.